Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)

BACKGROUND: Women with estrogen deficiencies can suffer from vaginal symptoms that negatively impact sexual health. This study evaluated vaginal dehydroepiandrosterone (DHEA) for alleviation of vaginal symptoms. METHODS: This three-arm randomized, controlled trial evaluated DHEA 3.25 mg and DHEA 6.5...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Support Care Cancer
Main Authors: Barton, Debra L., Sloan, Jeff A., Shuster, Lynne T., Gill, Paula, Griffin, Patricia, Flynn, Kathleen, Terstriep, Shelby A., Rana, Fauzia N., Dockter, Travis, Atherton, Pamela J., Tsai, Michaela, Sturtz, Keren, Lafky, Jacqueline M., Riepl, Mike, Thielen, Jacqueline, Loprinzi, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5754227/
https://ncbi.nlm.nih.gov/pubmed/28921241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-017-3878-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados